Jarrett Jennifer's Form 4 filing
Arcus Biosciences, Inc. (RCUS) · filed Jan 30, 2023
- Accession no.
- 0001209191-23-005513
- Filed
- Jan 30, 2023
- Trade date
- Jan 26-27, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $44.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jarrett JenniferCIK 0001671311 | Director, Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 26, 2023 | Common Stock | SSaleDisposed | −300 | $23.56 | −$7,068 | 416,546 | Direct | |
| Jan 27, 2023 | Common Stock | SSaleDisposed | −1,600 | $23.52 | −$37,632 | 414,946 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.